Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

New Nanodevice Defeats Drug Resistance

March 3, 2015 8:46 am | by Anne Trafton, MIT | News | Comments

Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. Read more...                     

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Roche Launches Next-Generation HBV Viral Load Assay in Select Markets

March 3, 2015 9:09 am | News | Comments

The new assay offers broad coverage of all known Hepatitis B (HBV) genotypes (A-H) with high sensitivity, across all critical medical decision points. Read more...                

TOPICS:

FDA Grants Orphan Drug Designation to Oncolytics' Cancer Treatment

March 3, 2015 9:03 am | News | Comments

Oncolytics has supported two sponsored clinical studies assessing reolysin in the treatment of peritoneal cancers. Read more...                     

TOPICS:

Australian Virus Might be Answer to Effective Ebola Vaccine

March 3, 2015 8:55 am | by University of Queensland | News | Comments

The study is one of the latest efforts in the worldwide race to find an effective Ebola vaccine. Read more...                         

TOPICS:
Advertisement

As Ebola Wanes, Other Countries Remain Vulnerable

March 3, 2015 8:41 am | by Krista Larson, Associated Press | News | Comments

Arriving airline passengers lined up outdoors to have their temperatures checked, the screens in the nighttime darkness like glowing lightning bugs. Read more...                

TOPICS:

Amgen Announces Results of Phase 3 Head-to-Head Study of Drugs for Multiple Myeloma

March 2, 2015 12:59 pm | News | Comments

Patients receiving one of the medications that was tested lived twice as long without disease progression. Read more...                       

TOPICS:

J&J Announces Binding Offer from Cardinal Health to Acquire Cordis

March 2, 2015 12:49 pm | News | Comments

The deal breaks down to an aggregate value of $1.99 billion. Read more...

TOPICS:

Preventing the Spread of Cancer with Copper Molecules

March 2, 2015 12:43 pm | by Bielefeld University | News | Comments

Chemists have developed a molecule containing copper that binds specifically with DNA and prevents the spread of cancer. Read more...                     

TOPICS:

An Opening for Measles

March 2, 2015 12:36 pm | by Colleen Walsh, Harvard Staff Writer | News | Comments

Anti-vaccination trend is becoming a growing concern. Read more...                                

TOPICS:
Advertisement

Survey: Parents Increasingly Ask Doctors to Delay Vaccines

March 2, 2015 12:29 pm | by Lindsey Tanner, AP Medical Writer | News | Comments

Parents have increasingly pressured doctors to delay vaccines for young children, making their kids and others vulnerable to preventable diseases. Read more...                 

TOPICS:

Firm Agrees to Refund to Settle Suit Over Weight-Loss Pills

March 2, 2015 12:23 pm | by Associated Press | News | Comments

Salt Lake City-based company has agreed to pay refunds to consumers who purchased its weight-loss tablets to settle a class-action lawsuit. Read more...                  

TOPICS:

New Target Identified in Fight Against Alzheimer's, Multiple Sclerosis

March 2, 2015 10:15 am | News | Comments

Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer's disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and other neurological diseases.

TOPICS:

How An FDA-Approved Drug Boosts Myelin Synthesis

March 2, 2015 10:11 am | News | Comments

Damage to myelin, the fatty insulator that enables communication between nerve cells, characterizes multiple sclerosis (MS) and other devastating neurological diseases. Read more...

TOPICS:

FDA Approves Actavis', Medicines360's Long-Term Contraception

March 2, 2015 10:06 am | News | Comments

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, announced the approval of Liletta (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration (FDA) for use by women to prevent pregnancy for up to three years. Read more...

TOPICS:

Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets

March 2, 2015 9:58 am | News | Comments

​Mylan N.V. and Mylan Inc. announced the successful completion of the acquisition of Abbott Laboratories' (NYSE: ABT) non-U.S. developed markets specialty and branded generics business. Read more..

TOPICS:

First Treatment Approved in Canada for Adults With ADPKD

March 2, 2015 9:52 am | News | Comments

Otsuka Pharmaceutical Co., Ltd. and its affiliate Otsuka Canada Pharmaceutical Inc. announce that Health Canada has approved JINARC (tolvaptan) as the first pharmaceutical agent for the treatment of autosomal dominant polycystic kidney disease (ADPKD). Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading